In order to further improve the standardized diagnosis and treatment level of tumors in our region, establish a preliminary tumor grading diagnosis and treatment system starting from cancer pain control, strengthen the clinical application management of anesthesia and psychotropic drugs at the grassroots level, and improve the quality of life of tumor patients, On November 10, 2023, the Cancer Quality Control Sub center of the High tech Zone held a special inspection and training session on the standardized diagnosis and treatment of cancer pain in grassroots medical institutions for the first batch of applicants, Chengdu High tech Good Doctor First Hospital. Duan Ping, Director of the Cancer Disease Quality Control Sub center of Chengdu High tech Zone, attended the meeting and delivered a speech.

  This meeting invited experts in oncology and pharmacy to conduct in-depth discussions and exchanges on topics such as the introduction of the grid based urban medical consortium's cancer pain project, overview and evaluation of cancer pain, drug treatment and adverse reaction management for cancer pain, opioid drug titration strategies, and anesthesia drug management. Participants expressed that through this training conference, they have learned about the latest cancer pain diagnosis and treatment technologies and concepts, which is of great significance for improving the diagnosis and treatment level of grassroots medical personnel and enhancing the quality of life of cancer patients.

  During the meeting, Chengdu High tech Good Doctor First Hospital reported on the progress of applying for a standardized diagnosis and treatment base for cancer pain. The hospital stated that they have been committed to improving the standardized diagnosis and treatment level of cancer pain, and have achieved certain results by continuously strengthening the training and management of medical personnel. In the future, hospitals will continue to increase efforts to promote the development of standardized diagnosis and treatment of cancer pain.

  Finally, the meeting conducted inspections on the standardized diagnosis and treatment of cancer pain in grassroots medical institutions. The inspection team experts carefully examined and evaluated the diagnosis and treatment behavior of grassroots medical personnel, and put forward some valuable opinions and suggestions. This is of great significance for improving the diagnosis and treatment level of grassroots medical personnel and safeguarding the legitimate rights and interests of patients.

  The successful holding of this conference marks an important step in the standardized diagnosis and treatment of tumors in Chengdu High tech Zone. In the future, grassroots medical institutions in Chengdu High tech Zone will continue to devote themselves to the development of standardized cancer diagnosis and treatment, promote the establishment of a more comprehensive cancer diagnosis and treatment system, and provide better medical services for cancer patients in the area.